Corcept Therapeutics Announces Fourth Quarter and Full-Year 2022 Audited Financial Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street futures edge lower after AI selloff, telecom slide
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on concern over Middle East escalation
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 107.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $107.50 | 52 Week High | $10.00 | |||
| Open | $107.50 | 52 Week Low | $3.22 | |||
| Day High | $107.50 | P/E | N/A | |||
| Day Low | $107.50 | EPS | $-0.46 | |||
| Volume | 245 | |||||
